Acadia Pharmaceuticals Inc (ACAD)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Baker Bros. Advisors

Julian Baker And Felix Baker

41,910,704 $1,022,202 4.48%
2.
D E Shaw

D. E. Shaw

4,765,065 $116,220 +103% 0.1%
3.
Partner Fund Management

Christopher Medlock James

2,807,310 $68,470 +116% 2.14%
4.
VenBio Select Advisor

Kurt Von Emster

2,441,658 $59,552 -3% 1.03%
5.
Palo Alto Investors

William Leland Edwards

2,337,877 $57,021 3.14%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$34.47 42,473 Large Shareholder, Director 38,433,977 2020-03-18 Filing
$34.47 3,837 Large Shareholder, Director 3,470,609 2020-03-18 Filing
$33.63 33,464 Large Shareholder, Director 38,391,504 2020-03-18 Filing
$33.63 3,023 Large Shareholder, Director 3,466,772 2020-03-18 Filing
$32.85 2,201 Large Shareholder, Director 38,358,040 2020-03-18 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$20.33 7,850 Officer, Director 49,312 2021-04-30 Filing
$20.33 4,230 Officer 36,434 2021-04-30 Filing
$20.33 1,054 Officer 11,371 2021-04-30 Filing
$20.33 1,032 Officer 10,553 2021-04-30 Filing
$50.61 2,051 Officer 8,340 2021-02-04 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 484,937 $11,827,614 0%
2. 92,959 $2,267,270 0.01%
3. 37,293 $909,576 0%
4. 35,288 $860,674 0%
5. 15,499,138 $378,024 0.03%
News See All